ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2022

Jan 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2022-01-07

Reporting Person: OLUKOTUN ADEOYE Y (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-07	Common Stock	A	6400	$0.00	Acquired	11350	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.